This is the authors' abstract. We don't add key points for this paper.
Background The novel coronavirus disease 2019 (COVID-19) spreads rapidly among people and causes a global pandemic. It is of great clinical significance to identify COVID-19 patients with high risk of death. Results Of the 2,169 COVID-19 patients, the median age was 61 years and male patients accounted for 48%. A total of 646 patients were diagnosed with severe illness, and 75 patients died. Obvious differences in demographics, clinical characteristics and laboratory examinations were found between survivors and non-survivors. A decision tree classifier, including three biomarkers, neutrophil-to-lymphocyte ratio, C-reactive protein and lactic dehydrogenase, was developed to predict death outcome in severe patients. This model performed well both in train dataset and test dataset. The accuracy of this model was 0.98 and 0.98, respectively. Conclusion The machine learning model was robust and effective in predicting the death outcome in severe COVID-19 patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: